FACULTAD DE CIENCIAS
Facultad
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (21)
2020
-
The urgent need for integrated science to fight COVID-19 pandemic and beyond
Journal of Translational Medicine, Vol. 18, Núm. 1
2019
-
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort
Liver International, Vol. 39, Núm. 1, pp. 90-97
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2017
-
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme
PLoS ONE, Vol. 12, Núm. 3
-
Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing
Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal
Medicine (United States), Vol. 93, Núm. 5, pp. 202-210
2013
-
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
PLoS ONE, Vol. 8, Núm. 1
2012
-
Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 71, Núm. 1, pp. 114-119
-
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
Genes and Immunity, Vol. 13, Núm. 2, pp. 191-196
2011
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology
2006
-
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplantation recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus
Liver Transplantation, Vol. 12, Núm. 10, pp. 1464-1472
2005
2003
-
Cardiovascular morbidity and obesity in adult liver transplant recipients
Transplantation Proceedings
-
Chronic renal dysfunction after liver transplantation in adult patients: Prevalence, risk factors, and impact on mortality
Transplantation Proceedings
-
De novo malignancies in liver transplantation
Transplantation Proceedings
-
Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation
Transplantation Proceedings
-
Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: Preliminary report
Transplantation Proceedings
-
Recurrence of primary biliary cirrhosis after liver transplantation
Transplantation Proceedings
-
Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas
Transplantation Proceedings